A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma-Reference-Cited by-同舟云学术

A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma

Published:2024-07-21 Issue: Volume: Page:1-11
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Jacobsen Eric¹,Plant Ashley²³,Redd Robert⁴,Armand Philippe¹,McDonough Mikaela¹,Ihuoma Udochukwu¹,Fisher David C.¹,LaCasce Ann¹,Ritz Jerome¹,Dranoff Glenn⁵,Freedman Arnold¹

Affiliation:

1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

2. Ann& Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA

3. Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

4. Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

5. Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA

Funder

Harold and Virginia Lash Foundation

Leukemia and Lymphoma Society

ASCO Cancer Foundation Career Development Award

K12 Paul Calabresi Clinical Oncology Award: Training in Nervous System Tumors

Publisher